Concepedia

Kay Hänggi

KH

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

2013

Affiliations

Moffitt Cancer Center(Current)

University of Zurich

Molecular Oncology (United States)

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

Kay Hänggi is an author at Moffitt Cancer Center specializing in oncology, life sciences, and cancer immunology.

Publications per year

2013–2024

13

Publications

13

The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake

Álvaro de Mingo Pulido, Kay Hänggi, Daiana P. Celias et al. · Immunity · 2021 · 244 citations · Full text

Life Sciences, Immunology, Oncology +12

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

Eslam Mohamed, Rosa A. Sierra, Jimena Trillo-Tinoco et al. · Immunity · 2020 · 218 citations · Full text

Medicine, Cell Biology, Oncology +10

Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Carmen M. Anadon, Xiaoqing Yu, Kay Hänggi et al. · Cancer Cell · 2022 · 170 citations · Full text

Life Sciences, Immunology, Oncology +17

Necroptosis Execution Is Mediated by Plasma Membrane Nanopores Independent of Calcium

Uris Ros, Aida Peña‐Blanco, Kay Hänggi et al. · Cell Reports · 2017 · 136 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics

Najoua Lalaoui, Kay Hänggi, Gabriela Brumatti et al. · Cancer Cell · 2016 · 102 citations · Full text

Medicine, Oncology, Pharmacology +9

1–5 of 13